NCT04333251View on ClinicalTrials.gov

Study Testing Convalescent Plasma vs Best Supportive Care

PHASE1UnknownINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Pneumonia, Interstitial
Interventions
BIOLOGICAL

high-titer anti-Sars-CoV-2 plasma

Recipients will receive 1-2 units of ABO matched donor plasma at neutralization antibody titer \>1:64 vs best supportive care

OTHER

oxygen therapy

oxygen therapy

Sponsors
All Listed Sponsors
lead

Baylor Research Institute

OTHER